Lancet Neurology
IF
30.04
Papers
4559
Papers 4831
1 page of 484 pages (4,831 results)
Newest
#1Merit Cudkowicz (Harvard University)H-Index: 80
#2Angela Genge (Montreal Neurological Institute and Hospital)H-Index: 21
Last. Ammar Al-Chalabi ('KCL': King's College London)H-Index: 90
view all 103 authors...
Summary null null Background null There is an urgent unmet need for new therapies in amyotrophic lateral sclerosis. In a clinical study with healthy volunteers, levosimendan, a calcium sensitiser, was shown to improve neuromechanical efficiency and contractile function of the human diaphragm. We aimed to evaluate the safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis, with a focus on respiratory function. null null null Methods null The REFALS study is a random...
2 CitationsSource
#1Shunsuke Koga (Mayo Clinic)H-Index: 23
#2Dennis W. Dickson (Mayo Clinic)H-Index: 216
Last. Zbigniew K. Wszolek (Mayo Clinic)H-Index: 101
view all 3 authors...
1 CitationsSource
#1Ludo van der Pol (UU: Utrecht University)H-Index: 5
Source
Source
#1Alessandra Fanciulli (Innsbruck Medical University)H-Index: 18
#2Gregor K. Wenning (Innsbruck Medical University)H-Index: 111
Source
#1Yehonatan Sharabi (TAU: Tel Aviv University)H-Index: 25
#2Gad Vatine (BGU: Ben-Gurion University of the Negev)H-Index: 14
Last. Avraham Ashkenazi (TAU: Tel Aviv University)H-Index: 15
view all 3 authors...
Patients with Parkinson's disease present with signs and symptoms of dysregulation of the peripheral autonomic nervous system that can even precede motor deficits. This dysregulation might reflect early pathology and therefore could be targeted for the development of prodromal or diagnostic biomarkers. Only a few objective clinical tests assess disease progression and are used to evaluate the entire spectrum of autonomic dysregulation in patients with Parkinson's disease. However, results from e...
1 CitationsSource
Source
Summary null null Background null Oral anticoagulation reduces the rate of systemic embolism for patients with atrial fibrillation by two-thirds, but its benefits for patients with previous intracranial haemorrhage are uncertain. In the Start or STop Anticoagulants Randomised Trial (SoSTART), we aimed to establish whether starting is non-inferior to avoiding oral anticoagulation for survivors of intracranial haemorrhage who have atrial fibrillation. null null null Methods null SoSTART was a pros...
Source
#1Angus Livingstone (University of Oxford)H-Index: 1
#2Laurent Servais (University of Oxford)H-Index: 37
Last. Dominic Wilkinson (John Radcliffe Hospital)H-Index: 29
view all 3 authors...
Source
#1Mamede de Carvalho (IMM: Instituto de Medicina Molecular)H-Index: 55
#2Michael Swash (QMUL: Queen Mary University of London)H-Index: 93
Source
12345678910
Top fields of study
Pathology
Psychology
Neuroscience
Physical therapy
Disease
MEDLINE
Stroke
Medicine